Literature DB >> 27873561

Antipsychotic drug exposure and risk of myocardial infarction.

C Barbui1, C Gastaldon1, D Papola1, G Ostuzzi1.   

Abstract

Patients experiencing psychoses and in need of antipsychotic agents may be exposed to a higher risk of myocardial infarction (MI) than the general population. As there have been no randomised studies investigating this association, a recent systematic review and meta-analysis included all observational studies that compared the incidence of MI among patients receiving antipsychotics v. no treatment. It found nine studies and calculated that the odds (risk) for developing MI were 1.88-fold higher in antipsychotic users compared with individuals who had not taken antipsychotic drugs. In this commentary, the results of this systematic review are discussed in view of their clinical implications for everyday clinical practice.

Entities:  

Keywords:  Antipsychotics; myocardial infarction; observational studies; psychosis; systematic reviews

Mesh:

Substances:

Year:  2016        PMID: 27873561      PMCID: PMC7137645          DOI: 10.1017/S204579601600086X

Source DB:  PubMed          Journal:  Epidemiol Psychiatr Sci        ISSN: 2045-7960            Impact factor:   6.892


  19 in total

Review 1.  Use of antipsychotics and risk of myocardial infarction: a systematic review and meta-analysis.

Authors:  Zheng-He Yu; Hai-Yin Jiang; Li Shao; Yuan-Yue Zhou; Hai-Yan Shi; Bing Ruan
Journal:  Br J Clin Pharmacol       Date:  2016-05-23       Impact factor: 4.335

2.  First-generation antipsychotics and QTc: any role for mediating variables?

Authors:  Giuseppe Carrà; Cristina Crocamo; Francesco Bartoli; Annamaria Lax; Martina Tremolada; Claudio Lucii; Giovanni Martinotti; Michela Nosè; Irene Bighelli; Giovanni Ostuzzi; Mariasole Castellazzi; Massimo Clerici; Corrado Barbui
Journal:  Hum Psychopharmacol       Date:  2016-06-01       Impact factor: 1.672

Review 3.  Antipsychotic drug exposure and risk of pneumonia: a systematic review and meta-analysis of observational studies.

Authors:  Michela Nosè; Elisabetta Recla; Gianluca Trifirò; Corrado Barbui
Journal:  Pharmacoepidemiol Drug Saf       Date:  2015-05-27       Impact factor: 2.890

4.  Clinicians' reasons for antipsychotic coprescribing.

Authors:  Michael J Sernyak; Robert Rosenheck
Journal:  J Clin Psychiatry       Date:  2004-12       Impact factor: 4.384

Review 5.  Cardiovascular safety of antipsychotics: a clinical overview.

Authors:  Christoffer Polcwiartek; Kristian Kragholm; Ole Schjerning; Claus Graff; Jimmi Nielsen
Journal:  Expert Opin Drug Saf       Date:  2016-04-01       Impact factor: 4.250

Review 6.  The association between antipsychotic agents and the risk of myocardial infarction: a systematic review.

Authors:  Ruth Brauer; Ian Douglas; Liam Smeeth
Journal:  Br J Clin Pharmacol       Date:  2011-12       Impact factor: 4.335

7.  Antipsychotic drug exposure and risk of pulmonary embolism: a population-based, nested case-control study.

Authors:  Valentino Conti; Mauro Venegoni; Alfredo Cocci; Ida Fortino; Antonio Lora; Corrado Barbui
Journal:  BMC Psychiatry       Date:  2015-04-29       Impact factor: 3.630

8.  Atypical antipsychotic drugs and the risk of sudden cardiac death.

Authors:  Wayne A Ray; Cecilia P Chung; Katherine T Murray; Kathi Hall; C Michael Stein
Journal:  N Engl J Med       Date:  2009-01-15       Impact factor: 176.079

9.  Observational research, randomised trials, and two views of medical science.

Authors:  Jan P Vandenbroucke
Journal:  PLoS Med       Date:  2008-03-11       Impact factor: 11.069

10.  Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval.

Authors:  Corrado Barbui; Irene Bighelli; Giuseppe Carrà; Mariasole Castellazzi; Claudio Lucii; Giovanni Martinotti; Michela Nosè; Giovanni Ostuzzi
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

View more
  3 in total

1.  Safety of psychotropic medicines: looking beyond randomised evidence.

Authors:  C Barbui; S B Patten
Journal:  Epidemiol Psychiatr Sci       Date:  2018-07-13       Impact factor: 6.892

2.  Association between antipsychotic use and acute ischemic heart disease in women but not in men: a retrospective cohort study of over one million primary care patients.

Authors:  Francisco T T Lai; Bruce Guthrie; Stewart W Mercer; Daniel J Smith; Benjamin H K Yip; Gary K K Chung; Kam-Pui Lee; Roger Y Chung; Patsy Y K Chau; Eliza L Y Wong; Eng-Kiong Yeoh; Samuel Y S Wong
Journal:  BMC Med       Date:  2020-11-02       Impact factor: 8.775

3.  Cardiovascular Events Associated with Antipsychotics in Newly Diagnosed Parkinson's Disease Patients: A Propensity Score Matched Cohort Study.

Authors:  Khalid Orayj
Journal:  Int J Gen Med       Date:  2021-06-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.